American Biotech Labs Announces Results of Preliminary Tests for Multiple Avian Bird Flu Strains Using Patented ABL SilverSol Technology™

SALT LAKE CITY--(BUSINESS WIRE)--American Biotech Labs (ABL; www.AmericanBiotechLabs.com), creator of a line of powerful products that utilize patented ABL SilverSol Technology™ to combat pathogens associated with many of the world’s most harmful diseases, today announced successful preliminary results on tests performed using the company’s products against two strains of the avian bird flu virus.

MORE ON THIS TOPIC